{"schema_version":"secwatch.filing_event.v1","accession":"0001553350-25-000168","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2025-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.493908+00:00","generated_at":"2026-05-16T15:54:05.706256+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"confidence":"high","headline":"Board member Gabe Ling resigns from The Oncology Institute board effective Dec 1, 2025","bullets":["Gabriel Ling resigned from the Board of Directors, effective December 1, 2025, with no disagreement with the company.","Chairman Anne McGeorge thanked Ling for his service during TOI's early years as a public company.","Formal search initiated for new independent directors with healthcare, clinical, and value-based care expertise."],"urls":{"canonical":"https://secwatch.observer/filing/0001553350-25-000168","json":"https://secwatch.observer/filing/0001553350-25-000168.json","markdown":"https://secwatch.observer/filing/0001553350-25-000168.md","text":"https://secwatch.observer/filing/0001553350-25-000168.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000168/0001553350-25-000168-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000168/toi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:54:05.706256+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}